← Leaderboards
Lennox J Jeffers
University Of Miami School Of Medicine
$1,407,404
Attributed
$1,407,404
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,407,404 · 1
By mechanism
U01$1,407,404 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- William J Harrington$5,964,578
- Emmanuel Thomas$4,555,992
- Glen N. Barber$22,145,694
- Robert Michael Malow$26,285,060
- Edward W Harhaj$12,325,910
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationInterferon AlphaChronic Disease /DisorderBiopsyCaucasian AmericanClinical TrialsCombination ChemotherapyGenotypeHepatitis CHepatitis C VirusHistologyHuman SubjectHuman Therapy EvaluationLongitudinal Human StudyMicroorganism Disease ChemotherapyPatient Oriented ResearchPolymerase Chain ReactionRibavirinSerumSocial PsychologySocioeconomicsTherapy ComplianceAfrican AmericanVirus Rna
Grant awards (6)
HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*$156,262
U01 · FY2005 · DK
HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*$175,000
U01 · FY2004 · DK
HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*$116,204
U01 · FY2004 · DK
HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*$375,000
U01 · FY2003 · DK
HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*$365,000
U01 · FY2002 · DK
HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*$219,938
U01 · FY2001 · DK